Results 51 to 60 of about 35,373 (217)

Transmission of yellow fever vaccine virus from breast feeding mothers to their infants: reporting of yellow fever virus (YFV) RNA detection in milk specimens [version 3; peer review: 1 approved, 2 approved with reservations]

open access: yesF1000Research, 2022
Background: Because of yellow fever’s serious impact on health, vaccination is the principal strategy to control the disease. Administration of the yellow fever vaccine to breastfeeding women should be before they complete 9 months post-delivery, in ...
Abdel Rahim M El Hussein   +6 more
doaj   +1 more source

Recurrent Respiratory Papillomatosis Foundation Position Statement on the Management of Adults With RRP

open access: yesThe Laryngoscope, EarlyView.
ABSTRACT Objective With regulatory approval of HPV‐specific immunotherapy for recurrent respiratory papillomatosis (RRP) and growing experience with systemic bevacizumab, a management algorithm incorporating these medical treatments is warranted. Data Sources and Methods RRP Foundation (RRPF) Key Opinion Leaders offer a proposed management algorithm ...
Simon R. Best   +17 more
wiley   +1 more source

Yellow fever vaccine : what you need to know [PDF]

open access: yes
Yellow fever is a serious disease caused by the yellowfever virus. It is found in certain parts of Africa andSouth America.Yellow fever is spread through the bite of an infected mosquito. It cannot be spread person to person by direct contact.1.

core   +2 more sources

Traditional Chinese Medicine for lung cancer: Mechanisms, clinical evidence, and future perspectives

open access: yesPrecision Medical Sciences, EarlyView.
Graphical abstract represents the risk factors for lung cancer, TCM efficacy and clinical outcomes to future challenges. Abstract Lung cancer remains a leading cause of global cancer mortality. Despite advances in conventional treatments such as surgery, chemotherapy, targeted therapy, and immunotherapy, challenges including drug resistance, toxicity ...
Zhangdeng Chen, Liujun Bao
wiley   +1 more source

Mitigating yellow fever vaccine associated viscerotropic disease in older travellers

open access: yes, 2020
In the 1930s, the development of a vaccine for humans toprevent or interrupt outbreaks of yellow fever,an acute viral haemorrhagic illness that is endemic in tropicaland sub-tropical areas of Africa, and Central and South America and in Trinidad, was ...
Fletcher, Rachael   +2 more
core   +1 more source

Yellow Fever Vaccination: An Issue for Non-endemic Tropical Countries

open access: yesInternational Journal of Travel Medicine and Global Health, 2018
Yellow fever is an important mosquito-borne infection. This disease is endemic in several tropical countries in Africa and South America. It is serious and can result in death. This disease can be prevented, and the best preventive measure is vaccination.
Viroj Wiwanitkit
doaj   +1 more source

Yellow fever virus: historical and current issues regarding recent epidemics and vaccination in Brazil

open access: yesHuman Vaccines & Immunotherapeutics, 2020
Yellow fever has been recently described in nonurban areas of Brazil despite 80 years of commercial vaccine use. Although the disease does not spread fear in the general population as it did in the past, yellow fever virus continues to cause many cases ...
Ricardo Ishak   +3 more
doaj   +1 more source

17‐epi‐Melianodiol, a new protolimonoid from Melia azedarach fruits, exhibits larvicidal activity and is associated with oxidative imbalance and midgut epithelial damage in Aedes aegypti larvae

open access: yesPest Management Science, EarlyView.
The bio‐guided phytochemical study resulted in the new compound 17‐epi‐melianodiol. The compound eliminated 100% of Aedes aegypti larvae at 100 ppm, causing pronounced morphological changes, cuticular damage, and extensive vacuolization. Abstract BACKGROUND In Brazil, Aedes aegypti is the primary vector of arboviruses such as dengue, chikungunya ...
Kethleen Duarte Crespo Soares   +8 more
wiley   +1 more source

Randomized, double-blinded, controlled non-inferiority trials evaluating the immunogenicity and safety of fractional doses of Yellow Fever vaccines in Kenya and Uganda [version 1; peer review: 2 approved]

open access: yesWellcome Open Research, 2019
Introduction: Yellow fever is endemic in specific regions of sub-Saharan Africa and the Americas, with recent epidemics occurring on both continents. The yellow fever vaccine is effective, affordable and safe, providing life-long immunity following a ...
Derick Kimathi   +5 more
doaj   +1 more source

Tick‐Borne Encephalitis (TBE) Vaccine in the National Immunisation Programme—For Whom, When and Where?

open access: yesActa Paediatrica, EarlyView.
ABSTRACT The incidence of Tick‐borne encephalitis (TBE) cases has increased. The presumed location of transmission of Tick‐borne encephalitis virus (TBEV) has been expanding increasingly in the western parts of Europe during the past decade. There has also been an increased incidence of surveillance‐reported TBE cases in southern Sweden and southern ...
H. H. Askling, D. Zavadska
wiley   +1 more source

Home - About - Disclaimer - Privacy